Skip to content

GFDA Consulting

Active Private limited companyfounded 2018active for 8 yearsVleurgatse Steenweg 268, 1050 IxellesKBO/BCE: BE 0707.912.235

Lifetime

7 annual accounts with figures on one time axis
peak of €106,443 in 2025
€106,44315 months
peak of €66,806 in 2025
€66,80615 months
peak of €213,809 in 2024
€197,971▼ 7.4%
€126,625▲ 289%
Board1 name since 2018
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Financial year from 01-10-2024 to 31-12-2025, 15 months changes role from manager to director 16-06Dividend €82,644Debts from €32,573 to €126,625Investments €9,030Cash from €13,032 to €523

Key points

from the 2025 annual accounts

Equity

€197,971 ▼ 7.4%
213,8092024+66,806Profit-82,644Dividend197,9712025

GFDA Consulting paid out €82,644 in dividends. That is 124% of the 2025 profit.

Turnover

≈ €180,000 estimated

The micro format states no turnover.

Debts

€126,625 ▲ 289%
Other debts
+79,606
Suppliers
+11,454
Taxes and wages
+2,992

Debts rose by €94,052 in 2025. A dividend stands under other debts on the balance sheet date until it is paid.

Investments

€9,030 4.1 times depreciation
202120222025

Green is investment, beige is depreciation.

Liquidity

2.50 was 7.53 in 2024

Short-term debts rose from €32,573 to €126,625.

Filings

7 annual accounts 6 late
AprilJune31 JulyOctober202020222024

The 2021 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 26,972 companies had the same profile as GFDA Consulting has now. Each dot stands for 68 companies, two years later.

94.9%
were still trading
3.5%
stopped another way
1.6%
went bankrupt
  • Micro
  • 5 to 10 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,894 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.7% would go bankrupt within 24 months. In fact 1.8% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.4% 0.5%
3 0.6% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.4% 1.6%
7 1.7% 1.8%
8 1.9% 2.0%
9 3.1% 3.3%
10 5.9% 6.4%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 26,972 companies, not a prediction for GFDA Consulting. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 372 sharesdeed of 10-10-2018
  • 372 sharesdeed of 10-10-2018
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0707912235
changes role from manager to director Gazette deed
Incorporation Founded by and · 744 shares · appointed as manager · published on 10-10-2018 · Gazette deed
First establishment Vleurgatse Steenweg 268, Ixelles
All 15 events

Comparable companies

same main activity, similar in size and age
Company
GFDA Consulting Ixelles €324,597 €106,443 61.0% -
BUBBLE TREE Ixelles €307,342 €106,865 73.3% -
MSP INVESTMENT Ixelles €297,014 €100,478 35.2% -
ATROPAL Ixelles €326,100 €90,896 35.3% -
EIBSEE CONSULTING Ixelles €393,659 €102,511 97.8% -
R-Qubed (Europe) Ganshoren €291,182 €103,672 47.7% -
STUBIK Uccle €294,781 €99,569 97.3% -

These companies have the same main activity as GFDA Consulting: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €291,000 and €394,000, founded between 2018 and 2019.

Official details

Source: KBO
Status
Active since 08-10-2018Normal situation
Activity
Business and other management consultancyNACE 70200
Establishment unit
2.285.633.3681050 Ixelles, since 08-10-2018
Financial year end
31 December
Peppol
Reachable since 28-01-2026
Company details

Annual accounts 2025

€324,597
Filing
Filed on 31-08-2026
Financials

Insights on GFDA Consulting

GFDA Consulting files the micro format. That format states no turnover. The gross margin rose from €54,549 in 2019 to €106,443 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GFDA Consulting

What is the company number of GFDA Consulting?
The company number of GFDA Consulting is 0707.912.235. The VAT number is the same number with BE in front: BE 0707.912.235.
Where is GFDA Consulting based?
The registered office is at Vleurgatse Steenweg 268, 1050 Ixelles.Company details
What does GFDA Consulting do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of GFDA Consulting?
GFDA Consulting is a private limited company (BV).
When was GFDA Consulting founded?
GFDA Consulting was founded on 08-10-2018.
Is GFDA Consulting still active?
Yes, GFDA Consulting is an active enterprise in the KBO register.
What is the turnover of GFDA Consulting?
The turnover in financial year 2025 is about €180,000. This figure is estimated from the gross margin of €106,443 and 123 comparable companies (NACE 70200). It probably lies between €150,000 and €210,000.Financials
Is GFDA Consulting profitable?
In financial year 2025, GFDA Consulting made a profit of €66,806.
Where can I find the annual accounts of GFDA Consulting?
GFDA Consulting filed 7 annual accounts with the National Bank of Belgium, the latest for financial year 2025.

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.